EMILY BURCHETTE: Open Payments
NPI 1124731294 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $366 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $229 |
| Neurocrine BioSciences, Inc. | 2 | $156 |
| Mallinckrodt Hospital Products Inc. | 1 | $102 |
| ABIOMED | 1 | $45 |
| Haemonetics Corporation | 1 | $24 |
Products named: INGREZZA, TERLIVAZ, TEG6S HEMOSTASIS SYSTEM.
Industry payments across KY — which companies pay providers there.
